A double-blind placebo-controlled trial of low-dose ganciclovir to prevent cytomegalovirus disease after heart transplantation. [electronic resource]
Producer: 19950601Description: 32-8 p. digitalISSN:- 1053-2498
- Actuarial Analysis
- Cytomegalovirus -- isolation & purification
- Cytomegalovirus Infections -- epidemiology
- Double-Blind Method
- Drug Administration Schedule
- Female
- Ganciclovir -- administration & dosage
- Heart Transplantation
- Humans
- Immunosuppressive Agents -- therapeutic use
- Incidence
- Male
- Middle Aged
- Postoperative Complications -- epidemiology
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.